Cempra to Present Data on Solithromycin at ECCMID Highlighting Potential New Indications, Safety and Activity Spectrum

Cempra to Present Data on Solithromycin at ECCMID Highlighting Potential New Indications, Safety and Activity Spectrum

[GlobeNewswire] – CHAPEL HILL, N.C. — Cempra, Inc. today announced that it will present data at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Barcelona, Spain, that continue to enhance … more

View todays social media effects on CEMP

View the latest stocks trending across Twitter. Click to view dashboard

See who Cempra is hiring next, click here to view

Share this post